On February 16, 2024, Steve Williamson informed Outset Medical, Inc. of his decision to depart from the Company and his role as Chief Commercial Officer, effective March 1, 2024, to become the CEO of another publicly traded medical device company. Mr. Williamson?s departure is not due to any dispute or disagreement with the Company or its management.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.555 USD | -0.14% | +9.17% | -34.01% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.01% | 184M | |
+12.79% | 229B | |
+14.45% | 195B | |
+18.02% | 142B | |
+28.87% | 109B | |
+3.27% | 64.85B | |
+18.56% | 54.33B | |
+7.63% | 52.09B | |
+11.28% | 45.15B | |
+5.84% | 37.39B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Announces Departure of Steve Williamson as Chief Commercial Officer, Effective March 1, 2024